- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: August 2014
- Public Summary Document (PSD) August 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) August 2014 PBAC Meeting - Word
Eculizumab – August 2014
Eculizumab, 300 mg/30 mL injection, 1 x 30mL vial injection, Soliris®
Last updated
8 November 2023